Comparison of diverse affinity based high-abundance protein depletion strategies for improved bio-marker discovery in oral fluids

Journal of Proteomics

Volumn 75, Issue 13, 2012, Pages 4165-4175

  Krief, Guy ^a   Deutsch, Omer ^a   Zaks, Batia ^a   Wong, David T ^b   Aframian, Doron J ^c   Palmon, Aaron ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Low abundance proteins; Oral fluid; Protein depletion; Quantitative proteomics; Saliva biomarker

Indexed keywords

ALBUMIN; AMYLASE; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; SALIVA PROTEIN;

ADULT; ARTICLE; BODY FLUID; CLINICAL ARTICLE; COMBINATORIAL PEPTIDE LIGAND LIBRARY; ENRICHED MULTIPLE DELETION; HUMAN; MALE; MULTIPLE DEPLETION; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEOMICS; SALIVA; TRIPLE DEPLETION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNINDEXED SEQUENCE;

ADULT; BIOLOGICAL MARKERS; BODY FLUIDS; COMBINATORIAL CHEMISTRY TECHNIQUES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MALE; PROTEINS; PROTEOMICS; SALIVA;

EID: 84862689887     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.05.012     Document Type: Article

References (40)

1. Wong D.T. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc 2006, 137(3):313-321.
2. Bandhakavi S., Stone M.D., Onsongo G., Van Riper S.K., Griffin T.J. A dynamic range compression and three-dimensional peptide fractionation analysis platform expands proteome coverage and the diagnostic potential of whole saliva. J Proteome Res 2009, 8(12):5590-5600.
3. Xiao H., Zhang L., Zhou H., Lee J.M., Garon E.B., Wong D.T. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteomics 2011.
4. Streckfus C.F., Mayorga-Wark O., Arreola D., Edwards C., Bigler L., Dubinsky W.P. Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast. Cancer Invest 2008, 26(2):159-167.
5. Stott-Miller M., Houck J.R., Lohavanichbutr P., Mendez E., Upton M.P., Futran N.D., et al. Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2011.
6. Rao P.V., Reddy A.P., Lu X., Dasari S., Krishnaprasad A., Biggs E., et al. Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res 2009, 8(1):239-245.
7. Baldini C., Giusti L., Ciregia F., Da Valle Y., Giacomelli C., Donadio E., et al. Proteomic analysis of saliva: a unique tool to distinguish primary Sjogren's syndrome from secondary Sjogren's syndrome and other sicca syndromes. Arthritis Res Ther 2011, 13(6):R194.
8. Hu S., Xie Y., Ramachandran P., Ogorzalek Loo R.R., Li Y., Loo J.A., et al. Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 2005, 5(6):1714-1728.
9. Deutsch O., Fleissig Y., Zaks B., Krief G., Aframian D.J., Palmon A. An approach to remove alpha amylase for proteomic analysis of low abundance biomarkers in human saliva. Electrophoresis 2008, 29(20):4150-4157.
10. Krief G., Deutsch O., Gariba S., Zaks B., Aframian D.J., Palmon A. Improved visualization of low abundance oral fluid proteins after triple depletion of alpha amylase, albumin and IgG. Oral Dis 2011, 17(1):45-52.
11. Yan W., Apweiler R., Balgley B.M., Boontheung P., Bundy J.L., Cargile B.J., et al. Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin Appl 2009, 3(1):116-134.
12. Polaskova V., Kapur A., Khan A., Molloy M.P., Baker M.S. High-abundance protein depletion: comparison of methods for human plasma biomarker discovery. Electrophoresis 2010, 31(3):471-482.
13. Liu T., Qian W.J., Mottaz H.M., Gritsenko M.A., Norbeck A.D., Moore R.J., et al. Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol Cell Proteomics 2006, 5(11):2167-2174.
14. Li X., Gong Y., Wang Y., Wu S., Cai Y., He P., et al. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project. Proteomics 2005, 5(13):3423-3441.
15. Bandow J.E. Comparison of protein enrichment strategies for proteome analysis of plasma. Proteomics 2010, 10(7):1416-1425.
16. Cho S.Y., Lee E.Y., Lee J.S., Kim H.Y., Park J.M., Kwon M.S., et al. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map. Proteomics 2005, 5(13):3386-3396.
17. Aframian D.J., Davidowitz T., Benoliel R. The distribution of oral mucosal pH values in healthy saliva secretors. Oral Dis 2006, 12(4):420-423.
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
19. Jessie K., Pang W.W., Haji Z., Rahim A., Hashim O.H. Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers. Int J Mol Sci 2010, 11(11):4488-4505.
20. Huang H.L., Stasyk T., Morandell S., Mogg M., Schreiber M., Feuerstein I., et al. Enrichment of low-abundant serum proteins by albumin/immunoglobulin G immunoaffinity depletion under partly denaturing conditions. Electrophoresis 2005, 26(14):2843-2849.
21. Zolotarjova N., Martosella J., Nicol G., Bailey J., Boyes B.E., Barrett W.C. Differences among techniques for high-abundant protein depletion. Proteomics 2005, 5(13):3304-3313.
22. Mao C., Tai W.C., Bai Y., Poizat C., Lee A.S. In vivo regulation of Grp78/BiP transcription in the embryonic heart: role of the endoplasmic reticulum stress response element and GATA-4. J Biol Chem 2006, 281(13):8877-8887.
23. Suyama K., Watanabe M., Sakabe K., Okada Y., Matsuyama D., Kuroiwa M., et al. Overexpression of GRP78 protects glial cells from endoplasmic reticulum stress. Neurosci Lett 2011.
24. Penas C., Guzman M.S., Verdu E., Fores J., Navarro X., Casas C. Spinal cord injury induces endoplasmic reticulum stress with different cell-type dependent response. J Neurochem 2007, 102(4):1242-1255.
25. Inokuchi Y., Nakajima Y., Shimazawa M., Kurita T., Kubo M., Saito A., et al. Effect of an inducer of BiP, a molecular chaperone, on endoplasmic reticulum (ER) stress-induced retinal cell death. Invest Ophthalmol Vis Sci 2009, 50(1):334-344.
26. Hayashi E., Kuramitsu Y., Fujimoto M., Zhang X., Tanaka T., Uchida K., et al. Proteomic profiling of differential display analysis for human oral squamous cell carcinoma: 14-3-3 sigma protein is upregulated in human oral squamous cell carcinoma and dependent on the differentiation level. Proteomics Clin Appl 2009, 3(11):1338-1347.
27. Qiu W., Hamernik R.P., Davis B. The kurtosis metric as an adjunct to energy in the prediction of trauma from continuous, nonGaussian noise exposures. J Acoust Soc Am 2006, 120(6):3901-3906.
28. Chen X., Wang S., Wu N., Yang C.S. Leukotriene A4 hydrolase as a target for cancer prevention and therapy. Curr Cancer Drug Targets 2004, 4(3):267-283.
29. Pani M.A., Regulla K., Segni M., Hofmann S., Hufner M., Pasquino A.M., et al. A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. J Clin Endocrinol Metab 2002, 87(6):2564-2567.
30. Speeckaert M., Huang G., Delanghe J.R., Taes Y.E. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 2006, 372(1-2):33-42.
31. Hirai M., Suzuki S., Hinokio Y., Hirai A., Chiba M., Akai H., et al. Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance. J Clin Endocrinol Metab 2000, 85(5):1951-1953.
32. Iyengar S., Hamman R.F., Marshall J.A., Majumder P.P., Ferrell R.E. On the role of vitamin D binding globulin in glucose homeostasis: results from the San Luis Valley Diabetes Study. Genet Epidemiol 1989, 6(6):691-698.
33. Szathmary E.J. The effect of Gc genotype on fasting insulin level in Dogrib Indians. Hum Genet 1987, 75(4):368-372.
34. Sandford A.J., Joos L., Pare P.D. Genetic risk factors for chronic obstructive pulmonary disease. Curr Opin Pulm Med 2002, 8(2):87-94.
35. Black P.N., Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 2005, 128(6):3792-3798.
36. Eales L.J., Nye K.E., Parkin J.M., Weber J.N., Forster S.M., Harris J.R., et al. Association of different allelic forms of group specific component with susceptibility to and clinical manifestation of human immunodeficiency virus infection. Lancet 1987, 1(8540):999-1002.
37. Niino M., Kikuchi S., Fukazawa T., Yabe I., Tashiro K. No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS. J Neuroimmunol 2002, 127(1-2):177-179.
38. Milman N., Thymann M., Graudal N., Morling N. Plasma vitamin D-binding protein (GC) factors, immunoglobulin G heavy chain (GM) allotypes and immunoglobulin kappa light chain (KM1) allotype in patients with sarcoidosis and in healthy control subjects. Sarcoidosis Vasc Diffuse Lung Dis 2002, 19(2):97-100.
39. Bahr G.M., Eales L.J., Nye K.E., Majeed H.A., Yousof A.M., Behbehani K., et al. An association between Gc (vitamin D-binding protein) alleles and susceptibility to rheumatic fever. Immunology 1989, 67(1):126-128.
40. Sreebny L.M., Schwartz S.S. A reference guide to drugs and dry mouth-2nd edition. Gerodontology 1997, 14(1):33-47.